{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:21:26Z","timestamp":1788009686869,"version":"build-2784847793"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Gout is increasingly recognized as a major chronic condition among older adults, contributing significantly to global disease burden, healthcare costs, and disability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study utilized data from the Global Burden of Disease (GBD) database, covering 204 countries and regions from 1990 to 2021. We evaluated age-standardized incidence rates, prevalence, and Years Lived with Disability (YLDs) of gout among individuals aged 60 years and older. Inequality and frontier analyses were conducted to explore disparities, and Bayesian Age-Period-Cohort (BAPC) models were applied for future trend projections up to 2036.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All indicators\u2014incidence, prevalence, and YLDs\u2014showed a steady increase across the study period, with particularly rapid growth observed in high Socio-demographic Index (SDI) regions and among older women. Although the burden was concentrated in high SDI countries, increasing trends were also evident in low SDI areas. Significant heterogeneity was found among countries with similar SDI levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The projected rise in gout burden through 2036 underscores the urgent need for targeted public health strategies. Disparities across SDI groups suggest that medical infrastructure, prevention programs, and cultural contexts play critical roles in disease control. Comprehensive interventions are essential to manage this growing challenge, especially among high-risk older populations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1577265","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T04:14:37Z","timestamp":1746072877000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Global burden and future projections of geriatric gout (1990\u20132021): a comprehensive analysis and Bayesian Age-Period-Cohort modeling"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiqing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S2665-9913(24)00117-6","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","article-title":"Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the global burden of disease study 2021","volume":"6","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.kint.2024.05.033","article-title":"Controversies and practical management of patients with gout and chronic kidney disease","volume":"106","author":"Johnson","year":"2024","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.3390\/ijms22179221","article-title":"Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease","volume":"22","author":"Yanai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/ard.2009.109884","article-title":"Menopause, postmenopausal hormone use and risk of incident gout","volume":"69","author":"Hak","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","article-title":"Gout epidemiology and comorbidities","volume":"50","author":"Singh","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1186\/s12889-024-20799-w","article-title":"Global, regional, and national burden of gout in elderly 1990-2021: an analysis for the global burden of disease study 2021","volume":"24","author":"Li","year":"2024","journal-title":"BMC Public Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/BOR.0000000000000861","article-title":"Update on gout management: what is old and what is new","volume":"34","author":"Afinogenova","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.semarthrit.2020.12.001","article-title":"The prevalence of gout and hyperuricaemia in Australia: an updated systematic review","volume":"51","author":"Pathmanathan","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"15953","DOI":"10.1038\/s41598-024-61616-z","article-title":"Burden of gout among different WHO regions, 1990-2019: estimates from the global burden of disease study","volume":"14","author":"Punjwani","year":"2024","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.47391\/JPMA.313","article-title":"A comprehensive review on gout: the epidemiological trends, pathophysiology, clinical presentation, diagnosis and treatment","volume":"71","author":"Ashiq","year":"2021","journal-title":"J Pak Med Assoc"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"767263","DOI":"10.3389\/fendo.2021.767263","article-title":"Bayesian age-period-cohort prediction of mortality of type 2 diabetic kidney disease in China: a modeling study","volume":"12","author":"Wu","year":"2021","journal-title":"Front Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"103498","DOI":"10.1016\/j.autrev.2023.103498","article-title":"Global, regional, and national burden of inflammatory bowel disease and its associated anemia, 1990 to 2019 and predictions to 2050: an analysis of the global burden of disease study 2019","volume":"23","author":"Wang","year":"2024","journal-title":"Autoimmun Rev"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2307\/2061165","article-title":"Decomposition of the difference between two rates with hierarchical factors","volume":"21","author":"Kim","year":"1984","journal-title":"Demography"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1126\/scitranslmed.3000237","article-title":"Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population","volume":"1","author":"Matsuo","year":"2009","journal-title":"Sci Transl Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/BOR.0000000000000571","article-title":"Genetic advances in gout: potential applications in clinical practice","volume":"31","author":"Tai","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/ajcn\/87.5.1480","article-title":"Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men","volume":"87","author":"Williams","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","article-title":"Management of Gout and Hyperuricemia in CKD","volume":"70","author":"Vargas-Santos","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1751-7176.2012.00674.x","article-title":"Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort","volume":"14","author":"McAdams-DeMarco","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"j1794","DOI":"10.1136\/bmj.j1794","article-title":"The dietary approaches to stop hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study","volume":"357","author":"Rai","year":"2017","journal-title":"BMJ"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1577265\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T04:14:41Z","timestamp":1746072881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1577265\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":23,"alternative-id":["10.3389\/fpubh.2025.1577265"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1577265","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"article-number":"1577265"}}